Vaccines – News and updates
14 January 2022 SAHPRA is currently evaluating a number of applications for emergency use (Section 2...
14 January, 22
News and Updates
-
-
SAHPRA and USP Announce MOU to Advance Regulatory Oversight for Medical Products in South Africa
14 January 2022 Embargo: Immediate release Joint Media Statement The South African Health Products R...
14 January, 22 -
SAHPRA approval of second/booster dose of the COVID-19 vaccine Janssen
23 December 2021 Embargo: Immediate release The South African Health Products Regulatory Authority (...
08 December, 21 -
SAHPRA approval of booster dosing with the Pfizer (Comirnaty®) COVID-19 vaccine
8 December 2021 Embargo: Immediate release The South African Health Products Authority (SAHPRA) init...
08 December, 21
SAHPRA TV and Podcasts
Stay up to date with our latest news, media coverages, interviews and announcements on SAHPRA TV.
LICENCES AND REGISTERS
AEFI reports microsite
The microsite provides information on reports of adverse events following immunisation (AEFIs) associated with COVID-19 vaccine administration.
Safety alerts
-
Risk of Drug-Induced Liver Injury associated with the use of Esbriet®
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20 -
MSA DIPHENHYDRAMINE-CONTAINING MEDICINES
SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma ...
01 November, 20 -
THE METFORMIN-CONTAINING MEDICINES THAT ARE REGISTERED AND IN PROCESS
The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulat...
12 October, 20 -
THE RANITIDINE-CONTAINING MEDICINES THAT ARE REGISTERED AND IN PROCESS
The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulat...
12 October, 20
SAHPRA Whistleblower
The SAHPRA hotline has been established with the aim of enhancing an honest work ethic and simultaneously providing the public with a mechanism to bring any unethical business practices to the attention of management.
PRODUCT RECALLS
Procter & Gamble South African Trading (Pty) Ltd, in consultation with the Medicines Control Council, wishes to alert the public that a small amount…
10 February 2017
This recall is initiated as a result of product quality complaint logged with Aspen Pharmacare due to the discloration of Lethyl 30 mg tablets…
31 July 2015
Following a customer complaint, we have identified the vitamin premix used in the manufacture of the affected product and batches contain additional vitamins and minerals…
UPCOMING AND PAST EVENTS
Stay up to date with SAHPRA’s upcoming, and past recorded events.
SOCIAL MEDIA FEEDS
Load More...
